Initial experience with ACT™ periurethral adjustable balloons to treat urinary incontinence due to intrinsic sphincter deficiency in the pediatric population
World Journal of Urology · 2023
DOI: 10.1007/s00345-023-04550-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Urology, 2023. Verfasst von Alice Faure und 6 weiteren Autor:innen. Beteiligte Einrichtung: APHM, Department of Pediatric Urology, CHU Timone Enfants, Marseille, France. alice.faure@ap-hm.fr. Hauptthemen laut MEDLINE: Urinary Incontinence, Urinary Incontinence, Stress, Urethral Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Themen: Inkontinenz
Abstract (Originalsprache)
PURPOSE: To present our initial experience with periurethral adjustable continence therapy (ACT™) for urinary incontinence due to intrinsic sphincter deficiency (ISD) in children. METHODS: This is an approved prospective non-randomized pilot study (NCT03351634) aiming to treat children born with spinal dysraphism (SD) or exstrophy epispadias complex (EEC) with ACT™. Endpoints were patient-reported changes in daily pad count, 24-h Pad test and complications. RESULTS: Since April 2018, 13 children (six girls, seven boys) were implanted at the median age of 12 years (5-16). The etiology of incontinence was neurogenic ISD (7/13, 54%) and EEC (6/13, 46%). After ACT™ implantation, continence (no pad or 1 security pad/day) was achieved in 9(69%) patients (5/7 SD, 4/6 EEC). Additionally, two (15%) patients had a significant improvement (decreasing Pad test from 1049 to 310 g at 3 months). One patient (7%) had no improvement. Results were stable at 21 months (6-43) of follow-up. Mean final balloon volume was 2.89 ml (± 0.85) with a median of 3 fillings to obtain continence. We had four revisions due to cutaneous port erosion (n = 3) and balloon migration (n = 1) and two definitive explantations. PinQ score was significantly improved (47 vs 40.5 with balloon, p = ns). Neither degradation of the upper urinary tract nor cystomanometric changes have been observed at 6 and 12 months postoperatively. CONCLUSION: Urinary incontinence due to ISD owing to EEC or SD can be successfully treated with ACT™ periurethral balloons. Given the minimal invasiveness of this therapy, it might be a first-line option treatment in children with complex stress urinary incontinence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- APHM, Department of Pediatric Urology, CHU Timone Enfants, Marseille, France. alice.faure@ap-hm.fr.
- Medicine Faculty, Aix-Marseille University, Marseille, France. alice.faure@ap-hm.fr.
- APHM, Department of Pediatric Urology, CHU Timone Enfants, Marseille, France.
- Medicine Faculty, Aix-Marseille University, Marseille, France.
- APHM, Department of Adult Urology and Kidney Transplantation, CHU La Conception, Marseille, France.
Zitieren
APA
Faure, A., Haddad, M., Pinol, J., Merrot, T., Guys, J. M., Michel, F., & Karsenty, G. (2023). Initial experience with ACT™ periurethral adjustable balloons to treat urinary incontinence due to intrinsic sphincter deficiency in the pediatric population. World Journal of Urology. https://doi.org/10.1007/s00345-023-04550-5
Vancouver
Faure A, Haddad M, Pinol J, Merrot T, Guys JM, Michel F, et al. Initial experience with ACT™ periurethral adjustable balloons to treat urinary incontinence due to intrinsic sphincter deficiency in the pediatric population. World Journal of Urology. 2023. doi:10.1007/s00345-023-04550-5
BibTeX
@article{Faure2023,
author = {Faure, Alice and Haddad, Mirna and Pinol, Jessica and Merrot, Thierry and Guys, Jean-Michel and Michel, Floriane and Karsenty, Gilles},
title = {Initial experience with ACT™ periurethral adjustable balloons to treat urinary incontinence due to intrinsic sphincter deficiency in the pediatric population},
journal = {World Journal of Urology},
year = {2023},
doi = {10.1007/s00345-023-04550-5}
}
EUVIMED